Építés alatt – nem éles oldal
Belépés

Gyomor- és nyelőcsőrák trials, also abroad

1484 open Gyomor- és nyelőcsőrák trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Kína723
Egyesült Államok273
Dél-Korea89
Franciaország81
Olaszország71
All other countries

The same trial often runs in several countries

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer has 5 sites in Argentína and runs in 28 countries. If a site near you is full, another one may still take people.

See A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer in all 28 countries